News & Events

InSysBio announces its participation in QSPC 2026 which is to be held from April 8-10, 2026 in Leiden, the Netherlands. InSysBio team is going to present its QSP modeling services & software to optimize drug development at Booth #3 and posters. Moreover, InSysBio will hold a workshop on Heta.

Engineering-Style QSP Modeling with Heta

InSysBio announces the upcoming workshop on Heta at QSPC 2026. The worksop will be held at Golden Tulip & Tulip Inn Leiden Centre, Leiden, the Netherlands on April 7, 2026, 1 PM – 5 PM.

InSysBio announces its participation in AGAH Conference 2026 (The Association for Applied Human Pharmacology) which is to be held from February 25-26, 2026 in Frankfurt, Germany. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, is going to present a poster selected for the Poster Pitch at Session 4 Poster Slam

The project aims at Quantitative Systems Pharmacology modeling of a T-cell engager to identify first-in-human dose and predict optimal step-up dosing regimen

InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the extension of collaboration with BeOne Medicines, a global oncology company.

The project aims at mechanistic PK/RO modeling to predict optimal dose and regimen of BGB-B2033, GPC3 x 4-1BB bispecific antibody

InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with BeOne Medicines, a global oncology company.

InSysBio launches a new data annotation service designed to support researchers and analysts who require specific, literature-based biological data to be added to InSysBio’s CYTOCON or fIVE databases for use in QSP modeling, analysis, or decision-making. The new service allows clients to submit targeted data requests related to diseases, tissues, cell types, and cytokines